Back to Current Sarcoma Research

ASSG Endorsed Clinical Study

ASSG19 - SMOC+

Title A surveillance study utilizing whole body magnetic resonance imaging and other surveillance procedures in people with germ line cancer gene mutations to investigate the prevalence and incidence of investigable lesions.
Objective A surveillance study utilizing whole body magnetic resonance imaging and other surveillance procedures in people with germ line cancer gene mutations to investigate the prevalence and incidence of investigable lesions.
Type Surveillance
Population 18-70 yrs with known cancer risk gene pathogenic mutation carrier or family member at 50% risk of carrying a mutation
Treatment Annual whole body magnetic resonance imaging, general physical exam, full blood count, and breast MRI, US and mammography(females). Other diagnostic procedures include colonoscopy and gastroscopy as indicated by family history.
Phase N/A
Drug / Intervention Early detection / Screening
Sponsor
Funding Source ASSG Johanna Sewell Sarcoma Research Grant, ASSG (PdCCRS)
Target accrual 150
Expected Completion 2019
Participating Sites
Recruitment Status Open to accrual
Numbers Accrued
Publications and Presentations
 
Principal Investigator A/Prof Paul James
Contact for Further Information Dr Mandy Ballinger
Contact Phone Number +61 2 9355 5806
Last update 01-Sep-2017 03:51 PM 

 

biospecimen
Clinical  Data
Contact ASSG